Maison Solutions (MSS)
Search documents
Maison Solutions (MSS) - 2025 Q2 - Quarterly Results
2024-12-16 22:10
Exhibit 99.1 Maison Solutions Reports Second Quarter and Six-Month 2025 Financial Results MONTEREY PARK, Calif. / ACCESSWIRE / December 16, 2024 / Maison Solutions Inc. (NASDAQ: MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the second quarter and six-months ended October 31, 2024. Management Commentary "I am pleased to announce another quarter of sequential and year- ...
Maison Solutions (MSS) - 2025 Q2 - Quarterly Report
2024-12-16 22:02
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41720 MAISON SOLUTIONS INC. (Exact name of registrant as specified in its charter) | --- | |---------------------------------------- ...
Maison Solutions (MSS) - 2025 Q1 - Quarterly Results
2024-09-23 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 001-41720 84-2498787 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) Title of each class Trading Symbol(s) Name of each exchange on which registered Class A common stock, $0.0001 par value per share MSS The Nasdaq Stock Market LLC FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported ...
Maison Solutions (MSS) - 2025 Q1 - Quarterly Report
2024-09-23 20:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41720 MAISON SOLUTIONS INC. (Exact name of registrant as specified in its charter) 84-2498797 (I.R.S. Employer Identification No.) Dela ...
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
GlobeNewswire News Room· 2024-09-16 07:01
- Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases for overall response rate (ORR) of 24% (4/17) with ADG126 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab - - Median progression-free survival of 8.5 months observed in patients without liver and peritoneal metastases at the ADG126 10 mg/kg Q3W dose - - At the 10 mg/kg dose level, 12-month overall survival (OS) rates were 74% for patients without liver metastases, ...
Maison Solutions (MSS) - 2024 Q4 - Annual Report
2024-08-13 20:45
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from ______ to ______ Commission File Number: 001-41720 Maison Solutions Inc. (Exact name of registrant as specified in its charter) | --- | --- | |--------------------------- ...
MAISON ALERT: Bragar Eagel & Squire, P.C. is Investigating Maison Solutions Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2024-08-10 01:00
NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Maison Solutions Inc. (NASDAQ: MSS) on behalf of long-term stockholders following a class action complaint that was filed against Maison on January 2, 2024 with a Class Period of (a) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection wit ...
Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC
Prnewswire· 2024-06-06 11:00
WALTHAM, Mass., June 6, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has advanced into the Phase 1b portion of its Phase 1/2 proof-of-concept trial of revumenib, the Company's highly selective, oral menin inhibitor, as a monotherapy in patients with relapsed or refractory (R/R) metastatic microsatellite stable (MSS) colorectal cancer (CRC). The Company's decision was suppo ...
Maison Solutions (MSS) - 2024 Q3 - Quarterly Results
2024-03-18 22:03
Exhibit 99.1 Maison Solutions Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results MONTEREY PARK, Calif., March 18, 2024 – Maison Solutions Inc. ("Maison Solutions" or the "Company"), (Nasdaq: MSS), a U.S.-based specialty grocery retailer offering traditional Asian food and merchandise to modern consumers, today announced financial results for the third quarter and first nine months of fiscal 2024 ended January 31, 2024. "We continue to make considerable operational progress through store reno ...
Maison Solutions (MSS) - 2024 Q3 - Quarterly Report
2024-03-18 21:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-41720 MAISON SOLUTIONS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...